Wachtlin, Joachim http://orcid.org/0000-0001-5355-5729
Eter, Nicole http://orcid.org/0000-0001-5617-346X
Hasanbasic, Zoran http://orcid.org/0000-0003-0673-012X
Keramas, Georgios
Rech, Christine
Sachs, Helmut
Schilling, Harald
Wiedemann, Peter http://orcid.org/0000-0002-5540-6847
Framme, Carsten http://orcid.org/0000-0001-8685-176X
Funding for this research was provided by:
Bayer Vital GmbH (EY1313)
Article History
Received: 30 January 2020
Revised: 29 April 2020
Accepted: 13 June 2020
First Online: 13 August 2020
Compliance with ethical standards
: Support was provided by Bayer Vital GmbH, Leverkusen, Germany. The sponsor participated in the design of the study, conducting the study, data collection, data management, data analysis, interpretation of the data, preparation, review, and approval of the manuscript. Medical writing (preparation of a manuscript draft) was provided by Dr. Kerstin Lindemann and Anna Jacob, medizinwelten-services GmbH, Stuttgart, Germany, and was funded by Bayer Vital GmbH. PERSEUS was sponsored by Bayer Vital GmbH, Leverkusen, Germany.
: Nicole Eter has received lecturer fees from Novartis, Bayer, Allergan, and Roche; has received a research grant from Novartis and Bayer; and serves on advisory boards for Novartis, Bayer, Allergan, and Roche. Carsten Framme has received research support from Novartis; has received lecturer fees from Bayer, Novartis, Zeiss, Allergan, and Heidelberg Engineering; and is a consultant for Bayer. Zoran Hasanbasic is an employee at Bayer Vital GmbH. Georgios Keramas is an employee at Bayer Vital GmbH. Christine Rech is an employee at Bayer Vital GmbH. Helmut Sachs has received a speaker honorarium from Bayer and serves on advisory boards for Bayer. Harald Schilling has received travel reimbursements from Bayer, Allergan, and Dorc and has received lecturer fees from Bayer. Joachim Wachtlin has received consultation and speaking honoraria from Novartis, Bayer, Alcon, and Allergan and serves on advisory boards for Bayer, Novartis, and Allergan. Peter Wiedemann participated in clinical studies conducted by Alimera Sciences, Bayer, Regeneron, ThromboGenics, Novartis, Chengdu, Hoya Vision,and Allergan.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.